[HTML][HTML] Long-term effects of SARS-CoV-2 infection on human brain and memory
Q Ding, HJ Zhao - Cell Death Discovery, 2023 - nature.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have caused
several waves of outbreaks. From the ancestral strain to Omicron variant, SARS-CoV-2 has …
several waves of outbreaks. From the ancestral strain to Omicron variant, SARS-CoV-2 has …
[HTML][HTML] Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: Retrospective cohort study and literature review
Background Most patients with SARS-CoV-2 are non-infectious within 2 weeks, though viral
RNA may remain detectable for weeks. However there are reports of persistent SARS-CoV-2 …
RNA may remain detectable for weeks. However there are reports of persistent SARS-CoV-2 …
[HTML][HTML] Novel treatment combining antiviral and neutralizing antibody-based therapies with monitoring of spike-specific antibody and viral load for …
D Wada, Y Nakamori, S Maruyama, H Shimazu… - … hematology & oncology, 2022 - Springer
Because prolonged viral replication of SARS-CoV-2 is increasingly being recognized
among immunocompromised patients, subacute or chronic COVID-19 pneumonia can …
among immunocompromised patients, subacute or chronic COVID-19 pneumonia can …
Clinical and Virological Outcome of Monoclonal Antibody Therapies Across Severe Acute Respiratory Syndrome Coronavirus 2 Variants in 245 Immunocompromised …
S Huygens, C GeurtsvanKessel… - Clinical Infectious …, 2024 - academic.oup.com
Abstract Background Immunocompromised patients (ICPs) have an increased risk for a
severe and prolonged COVID-19. SARS-CoV-2 monoclonal antibodies (mAbs) were …
severe and prolonged COVID-19. SARS-CoV-2 monoclonal antibodies (mAbs) were …
Intrinsic factors behind long COVID: IV. Hypothetical roles of the SARS‐CoV‐2 nucleocapsid protein and its liquid–liquid phase separation
A Eltayeb, F Al‐Sarraj, M Alharbi… - Journal of Cellular …, 2024 - Wiley Online Library
When the SARS‐CoV‐2 virus infects humans, it leads to a condition called COVID‐19 that
has a wide spectrum of clinical manifestations, from no symptoms to acute respiratory …
has a wide spectrum of clinical manifestations, from no symptoms to acute respiratory …
[HTML][HTML] Identifying markers of emerging SARS-CoV-2 variants in patients with secondary immunodeficiency
NM Markarian, G Galli, D Patel, M Hemmings… - Frontiers in …, 2022 - frontiersin.org
Since the end of 2019, the world has been challenged by the coronavirus disease 2019
(COVID-19) pandemic. With COVID-19 cases rising globally, severe acute respiratory …
(COVID-19) pandemic. With COVID-19 cases rising globally, severe acute respiratory …
Clinical and Virological Outcome of Monoclonal Antibody Therapies Across SARS-CoV-2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective …
S Huygens, C GeurtsvanKessel… - Clinical Infectious …, 2024 - academic.oup.com
Abstract Background Immunocompromised patients (ICPs) have an increased risk for a
severe and prolonged COVID-19. SARS-CoV-2 monoclonal antibodies (mAbs) were …
severe and prolonged COVID-19. SARS-CoV-2 monoclonal antibodies (mAbs) were …
Persistent SARS-CoV-2 infection in a patient with nephrotic syndrome under rituximab therapy: Successful treatment with a combination of remdesivir and monoclonal …
A Shimizu, I Shirai, K Ogawa, A Miura, K Haruhara… - Internal …, 2022 - jstage.jst.go.jp
Rituximab is an effective treatment for frequently relapsing/steroid-dependent nephrotic
syndrome, but there is concern about infections caused by humoral immunodeficiency. We …
syndrome, but there is concern about infections caused by humoral immunodeficiency. We …
COVID-19-Related Pneumonitis in Immunocompromised Patients: Reviewing Clinical Features and Management Approaches
A Nasrullah, H Shakir, E Khan… - Journal of …, 2024 - scholarlycommons.gbmc.org
In this case series, we explore persistent SARS-CoV-2 infection and its resultant
pneumonitis within a cohort of immunocompromised patients. We elucidate the complex …
pneumonitis within a cohort of immunocompromised patients. We elucidate the complex …
[HTML][HTML] 免疫抑制治疗下新冠病毒核酸反复复阳1 例报告并文献复习
王倩， 张琪然， 张怡， 陈彤 - Chinese Journal of Hematology, 2023 - ncbi.nlm.nih.gov
血液系统疾病患者因原发病及相关治疗常引起不同程度的免疫抑制. 新型冠状病毒肺炎(
coronavirus disease-2019, COVID-19) 流行期间, 部分免疫抑制状态的患者受到感染 …
coronavirus disease-2019, COVID-19) 流行期间, 部分免疫抑制状态的患者受到感染 …